- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07155460
- Original Trial
High Dimensional Computing Gesture Recognition (HDC-GCog)
The primary objective of this study is the Improvement of gesture recognition and classification accuracy through the use of the HDC algorithm compared to other classification methods (KNN, RF, SGD, NC). The recognition rate will be expressed by the sensitivity and specificity of gesture recognition. The model will be trained on a portion of the dataset and tested on the remaining part to avoid any bias.
The secondaries objectives are the :
- Improvement of gesture recognition accuracy with our HDC algorithm compared to other standard models.
- Calculation of gesture recognition rates depending on the number of electrodes used and their position.
- Subject's assessment of device comfort rated above 6 on a 10-level visual analog scale.
- Subject's assessment of ease of performing the gesture rated above 6 on a 10-level visual analog scale.
Study Overview
Detailed Description
This project aims to work on gesture recognition based on surface electromyography (EMG) recorded on the forearm. The CEA is currently developing a learning algorithm based on hyperdimensional computing designed to improve the accuracy and latency of gesture recognition. Unlike conventional computing methods, the developed approach relies on (pseudo) random hypervectors. This brings significant advantages: a simple algorithm with a well-defined set of arithmetic operations, extremely robust to noise and errors, with fast, one-pass learning that could ultimately benefit from a memory-centric architecture with a high degree of parallelism.
This research could lead to multiple applications, such as video gaming or the metaverse, but also strongly interests the healthcare field, for example in robotic prostheses, tele-surgery applications, or simply medical training using virtual reality applications.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daniel ANGLADE, MD, PhD
- Phone Number: 04 38 78 17 46
- Email: danglade@chu-grenoble.fr
Study Contact Backup
- Name: Caroline SANDRE-BALLESTER, PhD
- Phone Number: 04 38 78 28 51
- Email: csandreballester@chu-grenoble.fr
Study Locations
-
-
-
Grenoble, France, 38054
- Clinatec Cea/Chuga
-
Contact:
- Daniel ANGLADE, MD, PhD
- Phone Number: 04 38 78 17 46
- Email: danglade@chu-grenoble.fr
-
Contact:
- Caroline SANDRE-BALLESTER, PhD
- Phone Number: 04 38 78 28 51
- Email: csandreballester@chu-grenoble.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy, right-handed volunteer subject,
- Male or female,
- Age between 18 and 65 years inclusive,
- BMI < 30 kg/m²,
- Minimum forearm circumference less than 15 cm,
- Subjects agree to shaving or trimming of the right forearm.
- Agreement to the study non-opposition form,
- Subject affiliated with a social security scheme,
- Registered in the national database of individuals who participate in biomedical research
Exclusion Criteria:
- Subject with a known motor problem in the right forearm and hand,
- Known allergy or intolerance to one of the electrode components,
- Presence of a lesion in the measurement area,
- Subject with an active medical implant (e.g. pacemaker, cochlear implant, etc.),
- Subject wearing a contraceptive implant in the measurement area.
- Female subject aware of pregnancy at the time of measurement,
- Subject refusing to shave or trim the area or whose body hair precludes shaving or trimming the area,
- Presence of a pathology likely to alter the EMG.
- Persons referred to in Articles L1121-5 to L1121-8 of the Public Health Code (corresponds to all protected persons: pregnant women, women in labour, breastfeeding mothers, persons deprived of their liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8, persons admitted to a health or social establishment for purposes other than research, minors, persons subject to a legal protection measure or unable to express their consent).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HDC-GCog
High Dimensional Computing Gesture Recognition
|
Surface electromyography records
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gesture recognition rate using a device composed of 32 high-frequency surface EMG electrodes
Time Frame: 3 hours
|
Calculation of gesture recognition rate expressed in percentage of gesture recognition
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Real-time gesture recognition (latency <100ms)
Time Frame: 3 hours
|
Measurement of the improved gesture recognition rate with our HDC algorithm compared to other common models
|
3 hours
|
|
Validation of the positioning and number of electrodes used for EMG acquisition in order to maximize gesture recognition rates
Time Frame: 3 hours
|
Calculation of gesture recognition rates based on the number of electrodes used and their position
|
3 hours
|
|
Analysis of the subject's feedback regarding the ease of performing the gestures (in the form of a questionnaire)
Time Frame: 3 hours
|
Subject's rating of device comfort as greater than 6 on a 10-point visual analogue scale
|
3 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Salerno, A., Barraud, S. (2024). Evaluation and implementation of High-Dimensionnal Computing for gesture recognition using sEMG signals. Proceedings of the 2024 International Conference on Control, Automation and Diagnosis (ICCAD)
- Salerno, A., Barraud, S. (2025). Novel and efficient hyperdimensional encoding of surface electromyography signals for hand gesture recognition, Biosensor 2025.
- A. Sultana, F. Ahmed, Md. S. Alam, A systematic review on surface electromyography-based classification system for identifying hand and finger movements, Healthcare Analytics, 3, 100126, 2022, DOI:10.1016/j.health.2022.100126
- Sgambato, B. G., Castellano, G. (2022). Performance comparison of different classifiers applied to gesture recognition from sEMG signals. In Bastos-Filho, T. F., de Oliveira Caldeira, E. M., Frizera-Neto, A. (Eds.), XXVII Brazilian Congress on Biomedical Engineering. CBEB 2020. IFMBE Proceedings, Vol. 83. Springer, Cham
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 38RC25.0179
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on HDC-GCog
-
University of Turin, ItalyCompleted
-
Icahn School of Medicine at Mount SinaiUnknownMultiple Myeloma | Hodgkin's Disease | Chronic Lymphocytic Lymphoma | Relapsed Non-Hodgkin's LymphomaUnited States
-
Pascoe Pharmazeutische Praeparate GmbHCompleted
-
Aalborg UniversityNot yet recruiting
-
Sahlgrenska University Hospital, SwedenNot yet recruitingPancreatic Cancer | Surgery | Metastasis | Immunosuppression